Pharmacy Policies
These pharmacy policies apply to Medicare Advantage plans and the MyCare Ohio (Medicare-Medicaid) plan.
The policies below are in PDF format. If you do not have Adobe Acrobat Reader, you may download it here.
A
- Abraxane (paclitaxel albumin-bound suspension, intravenous infusion – Celgene, generic)
- Aduhelm® (aducanumab-avwa intravenous infusion – Biogen/Eisai)
- Alimta (pemetrexed intravenous infusion – Eli Lilly, generics)
- Aranesp® (darbepoetin alfa intravenous or subcutaneous injection − Amgen)
- Atgam® (lymphocyte immune globulin, anti-thymocyte globulin [equine] intravenous infusion – Pfizer)
B
C
D
F
H
I
K
L
O
P
S
T
U
Z
Cell and Gene Therapy Outcomes Tracking Program
CareSource Ohio Dual Advantage (D-SNP) partners with Audaire Health to capture and assess clinical benefits of Cell and Gene therapies. For more information, please refer to the CareSource Audaire Health™ Cell and Gene Therapy (CGT) Outcomes Tracking Program – Frequently Asked Questions for Providers. You can also find information about the program on our Updates & Announcements page.